NiKang Therapeutics

NiKang Therapeutics

DE - Wilmington
Biotechnology
WebsiteLinkedInCareers Page

Focus: Small Molecules for Oncology

NiKang Therapeutics is a life sciences company focused on Small Molecules for Oncology.

Oncology
Open Jobs
2

Pipeline & Clinical Trials

Phase 1
Clinical Trials (1)
NCT06264921A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors
Phase 1
NKT5097 CDK2/CDK4 dual degrader
HR+ Breast Cancer
Phase 1
Clinical Trials (1)
NCT07029399A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Phase 1
Phase 1
Clinical Trials (1)
NCT06586957A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Phase 1
Phase 1/2
Clinical Trials (1)
NCT04524871A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)
Phase 1/2
Oral NKT2152
ccRCC
Phase 1/2
Clinical Trials (1)
NCT05119335A Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma
Phase 1/2
NKT2152
ccRCC
Phase 2
Clinical Trials (1)
NCT05935748Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc)
Phase 2

Open Jobs (2)

Director/Senior Director, Legal (Contracts)

Supply Chain
1w ago

VP, Clinical Pharmacology and DMPK

Clinical
2w ago
Interview Prep Quick Facts
Founded: 2017
Portfolio: 6 clinical trials
Top TAs: Oncology, Nephrology
Publications: 5 in PubMed
Open Roles: 2 active jobs
Therapeutic Area Focus
Oncology
6 pipeline
Nephrology
1 pipeline
Marketed
Pipeline

Hiring Trend

Stable
2
Open Roles
+0
Added
-0
Filled/Removed

Based on last 4 crawl cycles